Get the Stockscreener App
18.07
0.25%
-0.055
Kodiak Sciences Inc stock is traded at $18.07, with a volume of 505.30K.
It is down -0.25% in the last 24 hours and up +20.05% over the past month.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
See More
Previous Close:
$18.12
Open:
$18.15
24h Volume:
505.30K
Relative Volume:
0.59
Market Cap:
$954.22M
Revenue:
-
Net Income/Loss:
$-197.68M
P/E Ratio:
-4.8059
EPS:
-3.76
Net Cash Flow:
$-158.88M
1W Performance:
-3.98%
1M Performance:
+20.05%
6M Performance:
+276.67%
1Y Performance:
+370.83%
1-Day Range:
$17.01
$18.67
1-Week Range:
$17.01
$21.17
52-Week Range:
$1.92
$21.17
Kodiak Sciences Inc Stock (KOD) Company Profile
Name
Kodiak Sciences Inc
Sector
Industry
Phone
650-281-0850
Address
1200 PAGE MILL RD, PALO ALTO, CA
Compare KOD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
18.07 | 957.39M | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-24-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-25-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-22-25 | Initiated | Jefferies | Buy |
| Aug-14-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-09-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| Dec-11-23 | Resumed | Goldman | Sell |
| Nov-17-23 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Jul-25-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-25-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-24-23 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-24-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-22 | Initiated | CapitalOne | Overweight |
| Aug-02-22 | Downgrade | Citigroup | Neutral → Sell |
| Feb-24-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | ROTH Capital | Neutral → Buy |
| Mar-12-21 | Initiated | Evercore ISI | Outperform |
| Mar-01-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-17-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Jan-25-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Nov-30-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-13-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-03-20 | Initiated | Goldman | Buy |
| Feb-18-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-06-20 | Initiated | SunTrust | Buy |
| Jan-08-20 | Initiated | ROTH Capital | Buy |
| Jan-03-20 | Initiated | Jefferies | Buy |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-20-19 | Initiated | Chardan Capital Markets | Buy |
| Oct-29-18 | Initiated | Barclays | Overweight |
| Oct-29-18 | Initiated | BofA/Merrill | Buy |
| Oct-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Kodiak Sciences Inc Stock (KOD) Latest News
Will Kodiak Sciences Inc. (K27) stock outperform foreign stocksQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Does Kodiak Sciences Inc. show high probability of reboundStock Surge & Community Consensus Stock Picks - newser.com
Analyzing recovery setups for Kodiak Sciences Inc. investorsMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Best data tools to analyze Kodiak Sciences Inc. stock2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
How Kodiak Sciences Inc. (K27) stock valuation compares with sector2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Will Kodiak Sciences Inc. stock maintain growth storyBear Alert & Low Drawdown Momentum Ideas - newser.com
Applying Elliott Wave Theory to Kodiak Sciences Inc.July 2025 Fed Impact & AI Optimized Trading Strategy Guides - newser.com
Should I hold or sell Kodiak Sciences Inc. stock in 2025Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Kodiak Sciences (KOD): Assessing Valuation After a 170% Three-Month Share Price Surge - Sahm
Is Kodiak Sciences Inc. trending in predictive chart modelsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Chart based exit strategy for Kodiak Sciences Inc.2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
What indicators show strength in Kodiak Sciences Inc.July 2025 Trends & Risk Managed Investment Signals - newser.com
Can technical indicators confirm Kodiak Sciences Inc.’s reversalTrade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
Is Kodiak Sciences Inc. stock a safe haven assetJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-11-02 01:33:26 - newser.com
Will Kodiak Sciences Inc. stock deliver consistent dividendsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Kodiak Sciences (NASDAQ:KOD) Shares Down 9.6%Should You Sell? - MarketBeat
What candlestick patterns are forming on Kodiak Sciences Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Kodiak Sciences (NASDAQ:KOD) Sets New 1-Year HighHere's Why - MarketBeat
LifeSci Capital Initiates Coverage of Kodiak Sciences (KOD) with Outperform Recommendation - MSN
Kodiak Sciences Shares Surge on Bullish Analyst Upgrades - AD HOC NEWS
How geopolitical risks impact Kodiak Sciences Inc. (K27) stockJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - newser.com
Chart overlay techniques for tracking Kodiak Sciences Inc.2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
KOD Crosses Above Average Analyst Target - Nasdaq
How Kodiak Sciences Inc. stock reacts to Fed rate cuts2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
What makes Kodiak Sciences Inc. (K27) stock appealing to growth investorsEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Is Kodiak Sciences Inc. stock ready for a breakoutWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Will Kodiak Sciences Inc. (K27) stock keep raising dividends2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Kodiak Sciences Inc Stock (KOD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):